Kenya

in page functions
[French]
Kenya
Total population (2016) 47,251,289
Birth cohort (2016) 1,586,294
Surviving Infants (surviving to 1 year per year, 2016) 1,508,163
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 49/1000
World Bank Index, IDA (2012) 3.79
Co-financing status (2016) Preparatory transition
No. of districts/territories (2015) 299

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Kenya

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Total $437,292,607 $437,292,607 $424,600,180
Cash Support (CASHSUPP) $348,000 $348,000 $145,000 42%
Health system strengthening (HSS 1) $9,903,000 $9,903,000 $8,334,292 84%
HPV Demo (NVS) $718,749 $718,749 $581,249 81%
Immunisation services support (ISS) $6,420,320 $6,420,320 $4,181,626 65%
Injection Safety Devices (NVS) $518,000 $518,000
Injection safety support (INS) $1,129,963 $1,129,963 $1,129,963 100%
IPV (NVS) $4,128,862 $4,128,862 $2,971,124 72%
Measles-Rubella (NVS) $13,513,824 $13,513,824 $13,513,824 100%
MR - Operational costs (OPC) $12,332,500 $12,332,500 $12,332,500 100%
Penta (NVS) $171,040,544 $171,040,544 $165,281,089 97%
Pneumo (NVS) $189,725,253 $189,725,253 $192,654,491 102%
Rotavirus (NVS) $22,708,182 $22,708,182 $18,746,406 83%
Vaccine Introduction Grant (VIG) $4,282,500 $4,282,500 $4,282,500 100%
Yellow Fever (NVS) $522,910 $522,910 $446,117 85%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Kenya DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 78%
M:F sex ratio at birth (2016) 1.03
Household survey: DTP3 coverage for male (2007) 82.90%
Household survey: DTP3 coverage for female (2007) 89.80%
Household survey: Last DTP3 survey (2007) 86%
% districts achieving > 80% DTP3 coverage (2015) 35%
% districts achieving < 50% DTP3 coverage (2015) 5%
MCV WHO/UNICEF estimates (2015) 75%

Breakdown of support

Non-vaccine support Vaccine support
7% 93%
$30,355,880 $394,194,296

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Kenya

18 January 2017

Vaccines being delivered by motorcycle in rural Kenya.

Deutsche Post DHL Group and Gavi forge global partnership to improve delivery of life-saving vaccines

Organisations to collaborate on addressing supply chain challenges to improve developing country access to life-saving vaccines. Test programme announced with Kenyan Health Ministry: DHL and Gavi to provide efficient transport management solution for vaccine distribution.

30 September 2016

UN logo

Gavi at the UNGA: diary of a public-private sector partnership

A week at the United Nations General Assembly is a long time in global health, especially for Gavi. The annual New York event brings together most members of the Vaccine Alliance - UN agencies, donor governments, implementing countries, businesses, philanthropies and civil society - and this diary records Gavi’s day-by-day efforts to strengthen collaboration and build new partnerships.

30 September 2016

Feature 7 Rwanda BG

Centre of Excellence for supply chain managers: a 'step' in the right direction

United Parcel Service (UPS), a global logistics company whose business it is to deliver packages to the far flung corners of the world, offers some potentially life- saving lessons to immunisation supply chain managers in developing countries.

close icon

modal window here